The Clorox Company (NYSE:CLX) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. reduced its stake in The Clorox Company (NYSE:CLX) by 44.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,931 shares of the company’s stock after selling 18,560 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Clorox were worth $3,270,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Prime Capital Investment Advisors LLC lifted its stake in Clorox by 18.2% during the fourth quarter. Prime Capital Investment Advisors LLC now owns 3,317 shares of the company’s stock valued at $473,000 after purchasing an additional 511 shares during the last quarter. Sowell Financial Services LLC lifted its stake in Clorox by 2.0% during the fourth quarter. Sowell Financial Services LLC now owns 20,232 shares of the company’s stock valued at $2,885,000 after purchasing an additional 399 shares during the last quarter. International Assets Investment Management LLC lifted its stake in Clorox by 17,658.5% during the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after purchasing an additional 481,725 shares during the last quarter. Arizona State Retirement System lifted its stake in Clorox by 1.0% during the fourth quarter. Arizona State Retirement System now owns 34,081 shares of the company’s stock valued at $4,860,000 after purchasing an additional 354 shares during the last quarter. Finally, Tsfg LLC lifted its stake in Clorox by 11.5% during the fourth quarter. Tsfg LLC now owns 920 shares of the company’s stock valued at $131,000 after purchasing an additional 95 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

NYSE CLX opened at $142.29 on Thursday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21. The company has a fifty day simple moving average of $150.40 and a 200 day simple moving average of $141.69. The company has a market cap of $17.66 billion, a P/E ratio of 225.86, a P/E/G ratio of 2.19 and a beta of 0.43.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the prior year, the firm earned $0.98 EPS. The business’s revenue was up 16.0% on a year-over-year basis. On average, sell-side analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CLX. JPMorgan Chase & Co. upped their price target on shares of Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. Citigroup reduced their price target on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a research report on Tuesday. Jefferies Financial Group upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a research report on Tuesday, March 26th. DA Davidson restated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research report on Wednesday. Finally, The Goldman Sachs Group initiated coverage on shares of Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 price target for the company. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.